3.17
price down icon1.55%   -0.05
 
loading
Precedente Chiudi:
$3.22
Aprire:
$3.17
Volume 24 ore:
6,118
Relative Volume:
0.03
Capitalizzazione di mercato:
$142.68M
Reddito:
$81.06M
Utile/perdita netta:
$-55.55M
Rapporto P/E:
-2.7807
EPS:
-1.14
Flusso di cassa netto:
$-47.98M
1 W Prestazione:
+14.86%
1M Prestazione:
+24.31%
6M Prestazione:
-41.19%
1 anno Prestazione:
-39.96%
Intervallo 1D:
Value
$3.05
$3.18
Intervallo di 1 settimana:
Value
$2.78
$3.44
Portata 52W:
Value
$2.03
$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name
Nome
Sight Sciences Inc
Name
Telefono
(415) 889-0550
Name
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Name
Dipendente
216
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
SGHT's Discussions on Twitter

Confronta SGHT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
SGHT
Sight Sciences Inc
3.18 142.68M 81.06M -55.55M -47.98M -1.14
Medical Devices icon
ABT
Abbott Laboratories
129.34 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
102.39 138.41B 17.55B 2.03B 2.37B 1.37
Medical Devices icon
SYK
Stryker Corp
367.17 129.62B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
84.21 107.92B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
76.30 40.53B 5.54B 4.18B 259.90M 7.00

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-06 Iniziato UBS Buy
2024-11-04 Downgrade Lake Street Buy → Hold
2024-08-21 Iniziato Lake Street Buy
2023-09-12 Downgrade BofA Securities Neutral → Underperform
2023-09-12 Downgrade Piper Sandler Overweight → Neutral
2023-09-12 Downgrade William Blair Outperform → Mkt Perform
2023-08-24 Downgrade Morgan Stanley Overweight → Equal-Weight
2023-07-10 Downgrade Citigroup Buy → Neutral
2023-01-06 Aggiornamento Stifel Hold → Buy
2022-10-04 Iniziato Needham Hold
2022-07-26 Iniziato Stifel Hold
2022-02-03 Iniziato William Blair Outperform
2022-01-07 Aggiornamento Morgan Stanley Equal-Weight → Overweight
Mostra tutto

Sight Sciences Inc Borsa (SGHT) Ultime notizie

pulisher
Apr 24, 2025

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times

Apr 24, 2025
pulisher
Apr 24, 2025

Sight Sciences, Inc. to Report First Quarter Financial Results on May 8, 2025 - Nasdaq

Apr 24, 2025
pulisher
Apr 24, 2025

Eyecare Tech Leader Sight Sciences Sets Q1 2025 Earnings Date: What Investors Should Watch - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Sight Sciences (SGHT) to Release Earnings on Thursday - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Sight Sciences Announces the Release of its Sustainability Report - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

Sight Sciences Sustainability Report Reveals Strong Gender Pay Equity, 14% Staff Retention Boost - Stock Titan

Apr 23, 2025
pulisher
Apr 23, 2025

Sight Sciences Appoints Gary Burbach to Board of Directors - VisionMonday.com

Apr 23, 2025
pulisher
Apr 22, 2025

Sight Sciences appoints new board member By Investing.com - Investing.com India

Apr 22, 2025
pulisher
Apr 22, 2025

Sight Sciences appoints new board member - Investing.com

Apr 22, 2025
pulisher
Apr 22, 2025

Sight Sciences Appoints Gary Burbach to its Board of Directors - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Sight Sciences Strengthens Board with Medtech Veteran as Glaucoma, Dry Eye Markets Transform - Stock Titan

Apr 22, 2025
pulisher
Apr 21, 2025

Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Sight Sciences to Debut OMNI® Edge Surgical System at the - GlobeNewswire

Apr 21, 2025
pulisher
Apr 21, 2025

Sight Sciences Unveils OMNI Edge: Next-Gen Glaucoma Surgery System with 2X Capacity | SGHT Stock News - Stock Titan

Apr 21, 2025
pulisher
Apr 15, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by American Century Companies Inc. - Defense World

Apr 15, 2025
pulisher
Apr 11, 2025

Sight Sciences (NASDAQ:SGHT) Earns Hold Rating from Needham & Company LLC - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Sight sciences CTO David Badawi sells $15,081 in stock - MSN

Apr 11, 2025
pulisher
Apr 10, 2025

April 2025's Top Penny Stocks To Watch - simplywall.st

Apr 10, 2025
pulisher
Apr 10, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Apr 10, 2025
pulisher
Apr 08, 2025

Sight Sciences at 24th Annual Needham Conference: Strategic Growth Insights - Investing.com Canada

Apr 08, 2025
pulisher
Apr 04, 2025

Sight sciences chief commercial officer sells $11,641 in stock By Investing.com - Investing.com India

Apr 04, 2025
pulisher
Apr 03, 2025

Sight Sciences stock hits 52-week low at $2.13 amid market challenges - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Sight sciences chief commercial officer sells $11,641 in stock - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Sight sciences CEO Paul Badawi sells shares worth $55,672 By Investing.com - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Sight sciences CTO David Badawi sells $13,771 in common stock By Investing.com - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 By Investing.com - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Sight sciences CTO David Badawi sells $13,771 in common stock - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Sight Sciences chief legal officer sells $21,693 in stock - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Sight Sciences chief legal officer sells $21,693 in stock By Investing.com - Investing.com UK

Apr 03, 2025
pulisher
Apr 03, 2025

Sight Sciences Executives Sell Shares to Cover Tax Liabilities - TradingView

Apr 03, 2025
pulisher
Apr 03, 2025

Sight Sciences stock hits 52-week low at $2.13 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Short Interest Update - Defense World

Apr 03, 2025
pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st

Mar 30, 2025
pulisher
Mar 29, 2025

Sight sciences chief legal officer sells shares worth $19,250 - MSN

Mar 29, 2025
pulisher
Mar 26, 2025

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire

Mar 26, 2025
pulisher
Mar 25, 2025

Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan

Mar 25, 2025
pulisher
Mar 25, 2025

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 25, 2025
pulisher
Mar 16, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia

Mar 15, 2025
pulisher
Mar 13, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India

Mar 13, 2025
pulisher
Mar 09, 2025

Piper Sandler Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.50 - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Sight Sciences’ (SGHT) Hold Rating Reiterated at Needham & Company LLC - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Stifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Mar 07, 2025
pulisher
Mar 07, 2025

Sight Sciences Inc. (SGHT) reports earnings - Quartz

Mar 07, 2025
pulisher
Mar 07, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results, Initiates Full Year 2025 Financial Guidance - Vision Monday

Mar 07, 2025

Sight Sciences Inc Azioni (SGHT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$101.33
price up icon 0.27%
medical_devices STE
$225.81
price up icon 0.07%
medical_devices PHG
$25.27
price up icon 2.22%
$68.42
price down icon 0.04%
$71.11
price down icon 0.55%
medical_devices EW
$76.34
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):